IL6 and infection: From the above, it is clear that a dual approach for PAM infection treatment should be used by reducing NF progression and limiting the neuronal and other organ damages that occur by selectively containing the immune system (by developing newer immuno-modulatory therapies namely targeting IL-6, for instance) that would lead to a greater margin of safety and clinical efficacy and increase the chances of winning the fight against this rare but fatal disease.